Compare Hims and Hers Health Inc (HIMS) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

MSTU, a 2x leveraged ETF tracking MicroStrategy, trades at $1.98 with a 6.45% daily gain but remains in a severe long-term downtrend, having lost over 95% in the past year. Technical indicators are bearish, with moving averages signaling strong selling pressure. The fund's performance is directly tied to MicroStrategy's stock, which is heavily influenced by Bitcoin price volatility, and recent news highlights extreme investor losses and high-risk nature of leveraged products.

The outlook for MSTU is highly speculative and risky, with potential for parabolic gains if Bitcoin surges but extreme downside risk during volatility. Investment suitability is limited to aggressive traders comfortable with total loss potential, given the fund's decay mechanisms and dependency on crypto market sentiment rather than traditional fundamentals.